Opportunity
SAM #36C26027Q0117
VA molecular diagnostic system and infectious-disease testing panels for Boise VAMC
Buyer
Vanco 20
Posted
November 09, 2026
Respond By
November 28, 2026
Identifier
36C26027Q0117
NAICS
325413, 423450
The Department of Veterans Affairs is seeking a molecular diagnostic testing system and infectious-disease panel reagents for Boise VA Medical Center. - Government buyer: Department of Veterans Affairs, Network Contract Office 20; Boise VA Medical Center. - Requested system: A high-throughput, FDA-approved molecular diagnostic system for rapid syndromic infectious-disease testing; no model or system quantity is stated. - Panel quantities: The listed annual quantities apply to the base period and each of four option periods: - Blood Culture Panel: 154 per year; 770 across five periods. - COVID 19 Diagnostic Panel: 626 per year; 3,130 across five periods. - Gastrointestinal PCR Panel: 409 per year; 2,045 across five periods. - Meningitis Encephalitis Panel: 16 per year; 80 across five periods. - Pneumonia Bal PCR Panel: 99 per year; 495 across five periods. - OEMs and vendors: No manufacturer, OEM, or vendor is identified in the provided materials. No part numbers are provided. - Notable requirement: The system and panels are intended to support rapid syndromic infectious-disease diagnostics. The acquisition is described as a rental purchase agreement, with additional products potentially ordered as needed.
Description
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.